Barry Reiner

450 total citations
8 papers, 327 citations indexed

About

Barry Reiner is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Barry Reiner has authored 8 papers receiving a total of 327 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Endocrinology, Diabetes and Metabolism, 2 papers in Surgery and 2 papers in Molecular Biology. Recurrent topics in Barry Reiner's work include Diabetes Management and Research (3 papers), Adrenal Hormones and Disorders (2 papers) and Growth Hormone and Insulin-like Growth Factors (2 papers). Barry Reiner is often cited by papers focused on Diabetes Management and Research (3 papers), Adrenal Hormones and Disorders (2 papers) and Growth Hormone and Insulin-like Growth Factors (2 papers). Barry Reiner collaborates with scholars based in United States, Canada and France. Barry Reiner's co-authors include Susan A. Henry, Miriam L. Greenberg, Harold E. Harrison, Michael F. Holick, Samuel J. Casella, Tai C. Chen, Larry C. Deeb, Leslie Plotnick, Zachary T. Goodman and Megan Adamson and has published in prestigious journals such as Gastroenterology, The Journal of Clinical Endocrinology & Metabolism and Genetics.

In The Last Decade

Barry Reiner

8 papers receiving 305 citations

Peers

Barry Reiner

MB

EDM

CB

ND

PFM

Sandra M. Sacco Canada

Justin Mathew United States

Takako Ishii Japan

M.N. Brunden United States

H. Coetzer South Africa

Surajeet Kumar Patra India

GM Wardlaw United States

Francisco Aguirre Chile

Jan L. Harryvan Netherlands

María E. Muñoz Spain

Sandra M. Sacco Canada

Barry Reiner

181 ×1.4

MB

46 ×0.5

EDM

18 ×0.3

CB

68 ×1.3

ND

90 ×1.8

PFM

Citations per year, relative to Barry Reiner Barry Reiner (= 1×) peers Sandra M. Sacco

Countries citing papers authored by Barry Reiner

Since Specialization

Citations

This map shows the geographic impact of Barry Reiner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barry Reiner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barry Reiner more than expected).

Fields of papers citing papers by Barry Reiner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barry Reiner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barry Reiner. The network helps show where Barry Reiner may publish in the future.

Co-authorship network of co-authors of Barry Reiner

This figure shows the co-authorship network connecting the top 25 collaborators of Barry Reiner. A scholar is included among the top collaborators of Barry Reiner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barry Reiner. Barry Reiner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Reiner, Barry, et al.. (2020). Human plasma‐derived alpha ₁ ‐proteinase inhibitor in patients with new‐onset type 1 diabetes mellitus: A randomized, placebo‐controlled proof‐of‐concept study. Pediatric Diabetes. 22(2). 192–201. 5 indexed citations

2.

Deeb, Larry C., Hélène Dulude, Cristina B. Guzmán, et al.. (2018). A phase 3 multicenter, open-label, prospective study designed to evaluate the effectiveness and ease of use of nasal glucagon in the treatment of moderate and severe hypoglycemia in children and adolescents with type 1 diabetes in the home or school setti. Pediatric Diabetes. 19(5). 1007–1013. 42 indexed citations

3.

Backeljauw, Philippe, Bradley S. Miller, Aude Houchard, et al.. (2015). Recombinant Human Growth Hormone Plus Recombinant Human Insulin-Like Growth Factor-1 Coadministration Therapy in Short Children with Low Insulin-Like Growth Factor-1 and Growth Hormone Sufficiency: Results from a Randomized, Multicenter, Open-Label, Parallel-Group, Active Treatment-Controlled Trial. Hormone Research in Paediatrics. 83(4). 268–279. 18 indexed citations

4.

Hey‐Hadavi, Judith, Andreas M. Pleil, Larry C. Deeb, et al.. (2010). Ease of use and preference for a new disposable self-injection pen compared with a reusable pen for administering recombinant human growth hormone: A multicenter, 2-Month, single-arm, open-label clinical trial in patient-caregiver dyads. Clinical Therapeutics. 32(12). 2036–2047. 19 indexed citations

5.

Casella, Samuel J., Barry Reiner, Tai C. Chen, Michael F. Holick, & Harold E. Harrison. (1994). A possible genetic defect in 25-hydroxylation as a cause of rickets. The Journal of Pediatrics. 124(6). 929–932. 57 indexed citations

6.

Adamson, Megan, Barry Reiner, Jean L. Olson, et al.. (1992). Indian childhood cirrhosis in an American child. Gastroenterology. 102(5). 1771–1777. 45 indexed citations

7.

Reiner, Barry, et al.. (1989). Serum 3α-Androstanediol Glucuronide Measurements in Sexually Mature Women with Congenital Adrenal Hyperplasia during Therapy*. The Journal of Clinical Endocrinology & Metabolism. 69(1). 105–109. 11 indexed citations

8.

Greenberg, Miriam L., Barry Reiner, & Susan A. Henry. (1982). REGULATORY MUTATIONS OF INOSITOL BIOSYNTHESIS IN YEAST: ISOLATION OF INOSITOL-EXCRETING MUTANTS. Genetics. 100(1). 19–33. 130 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact